BIOMARKER:

EGFR exon 18 mutation

Entrez ID:

Related biomarkers:

‹

›

EGFR exon 18 mutation EGFR exon 18 mutation	Non Small Cell Lung Cancer NSCLC	bevacizumab + erlotinib Sensitive: C3 – Early Trials
EGFR exon 18 mutation EGFR exon 18 mutation	Non Small Cell Lung Cancer NSCLC	neratinib Sensitive: C3 – Early Trials
EGFR exon 18 mutation EGFR exon 18 mutation	Lung Adenocarcinoma LUAD	bevacizumab + afatinib Sensitive: C4 – Case Studies

Associations